[Skip to Content]
[Skip to Content Landing]
Practice Gaps
May 2013

Toward a Better Definition of High-Risk Cutaneous Squamous Cell CarcinomaComment on “Factors Predictive of Recurrence and Death From Cutaneous Squamous Cell Carcinoma”

Author Affiliations

Author Affiliation: Department of Dermatology, Emory University School of Medicine, The Emory Clinic, Atlanta, Georgia.

JAMA Dermatol. 2013;149(5):547-548. doi:10.1001/jamadermatol.2013.24

Patient prognosis varies considerably among various types of skin cancer. Approximately 5% of cutaneous squamous cell carcinomas (CSCCs) metastasize, usually to regional nodes.1 A recent staging system has been developed for CSCC that combines tumor diameter with high-risk features, including primary tumor size greater than 2 cm, Breslow thickness greater than 2 mm, Clark level IV or greater, perineural invasion, poor differentiation, and primary site on the ear or lip, to classify tumors as T1 or T2. These high-risk factors have prognostic significance, particularly among immunocompromised patients. Immunosuppression contributes negatively to the prognosis and outcome of patients with CSCC; however, because strict TNM criteria exclude clinical risk factors in staging, immunosuppression was not included in the staging system.

First Page Preview View Large
First page PDF preview
First page PDF preview